Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Ranasinghe, D; Lin, WY; Fordham, SE; Alharbi, AA; Sunter, NJ; Elstob, C; Nahari, MH; Xu, Y; Park, C; Hungate, E; Quante, A; Strauch, K; Gieger, C; Skol, AD; Rahman, T; Sucheston-Campbell, L; Hahn, T; Clay-Gilmour, AI; Jones, GL; Marr, HJ; Jackson, GH; Menne, T; Collin, M; Ivey, A; Hills, RK; Burnett, AK; Russell, NH; Fitzgibbon, J; Larson, RA; Le, Beau, MM; Stock, W; Heidenreich, O; Enshaei, A; Gunasinghe, D; Hawking, ZL; Heslop, HS; Nandana, D; Di, B; Plokhuta, A; Brown, IT; Allsup, DJ; Houlston, RS; Collins, A; Milne, P; Norden, J; Dickinson, AM; Lendrem, BC; Daly, AK; Palm, L; Piechocki, K; Jeffries, S; Bornhäuser, M; Röllig, C; Altmann, H; Ruhnke, L; Kunadt, D; Wagenführ, L; Cordell, HJ; Darlay, R; Andersen, MK; Fontana, MC; Martinelli, G; Marconi, G; Sanz, MÁ; Cervera, J; Gomez-Segui, I; Cluzeau, T; Moreilhon, C; Raynaud, S; Sill, H; Voso, MT; Dombret, H; Cheok, MH; Preudhomme, C; Gale, RE; Linch, DC; Weisinger, J; Masszi, A; Nowak, D; Hofmann, WK; Gilkes, AF; Porkka, K; Milosevic, Feenstra, JD; Kralovics, R; Wang, J; Meggendorfer, M; Haferlach, T; Krizsán, S; Bödör, C; Parkin, BL; Malek, SN; Stölzel, F; Onel, K; Allan, JM.
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia.
Blood. 2026; Doi: 10.1182/blood.2025031266
PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Sill Heinz

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Acute myeloid leukemia (AML) is a complex hematological malignancy with multiple disease sub-groups defined by somatic mutations and heterogeneous outcomes. Although genome-wide association studies (GWAS) have identified a small number of common genetic variants influencing AML risk, the heritable component of this disease outside of familial susceptibility remains largely undefined. Here we perform a meta-analysis of four published GWAS plus two new GWAS, totalling 4710 AML cases and 12938 controls. We identify a new genome-wide significant risk locus for pan-AML at 2p23.3 (rs4665765; P=1.35x10-8; EFR3B, POMC, DNMT3A, DNAJC27) which also significantly associates with patient survival (P=6.09x10-3). Our analysis also identifies three new genome-wide significant risk loci for disease sub-groups, including AML with deletions of chromosome 5 and/or 7 at 1q23.3 (rs12078864; P=7.0x10-10; DUSP23) and cytogenetically complex AML at 2q33.3 (rs12988876; P=3.28x10-8; PARD3B) and 2p21 (rs79918355; P=1.60x10-9; EPCAM). We also investigated loci previously associated with risk of clonal hematopoiesis (CH) or clonal hematopoiesis of indeterminate potential (CHIP) and identified several variants associated with risk of AML. Our results further inform on AML etiology and demonstrate the existence of disease sub-group specific risk loci.

© Med Uni Graz • Imprint